Spondyloarthropathies: traitements conventionnels et anti-TNF [Spondylarthropathies: conventional treatments and anti-TNF]

Details

Ressource 1Download: RMS_509_507.pdf (547.88 [Ko])
State: Public
Version: Final published version
License: CC BY-NC-ND 4.0
Serval ID
serval:BIB_5F771CC8B05F
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Spondyloarthropathies: traitements conventionnels et anti-TNF [Spondylarthropathies: conventional treatments and anti-TNF]
Journal
Revue medicale suisse
Author(s)
Dumusc A., So A.
ISSN
1660-9379 (Print)
ISSN-L
1660-9379
Publication state
Published
Issued date
09/03/2016
Peer-reviewed
Oui
Volume
12
Number
509
Pages
507-508,510-511
Language
french
Notes
Publication types: English Abstract ; Journal Article
Publication Status: ppublish
Abstract
Non-steroidal anti-inflammatory drugs (NSAID) are the first line treatment for spondylarthritis. NSAIDs are effective when used continuously or on demand, in short or long-term use. An effect on radiologic progression of the spine is still controversial. However, physicians have to be aware of potential cardiovascular, renal or gastro-intestinal secondary effects when prescribing NSAIDs. DMARDs like methotrexate or systemic corticosteroids are generally not recommended for the treatment of spondylarthritis. After NSAIDs failure, a TNF inhibitor can be used. 5 anti-TNF are available in Switzerland and they are all effective in this disease. Before starting an anti-TNF treatment, a screening is mandatory. Patients treated with an anti-TNF must be followed regularly.
Keywords
Anti-Inflammatory Agents, Non-Steroidal/therapeutic use, Antirheumatic Agents/therapeutic use, Humans, Meta-Analysis as Topic, Randomized Controlled Trials as Topic, Spondylarthropathies/drug therapy, Switzerland, Time Factors, Treatment Outcome, Tumor Necrosis Factor-alpha/antagonists & inhibitors
Pubmed
Create date
25/01/2017 14:04
Last modification date
21/01/2025 8:20
Usage data